Da der kun findes få patienter med disse sygdomme, blev Atriance udpeget som "lægemiddel til sjældne sygdomme" den 16. juni 2005.
Because the number of patients with these diseases is low, the diseases are considered ‘ rare’, and Atriance was designated an ‘ orphan medicine ’ (a medicine used in rare diseases) on 16 June 2005.